PBX3 promotes migration and invasion of colorectal cancer cells via activation of MAPK/ERK signaling pathway.

AIM To investigate the role of pre-B-cell leukemia homeobox (PBX)3 in migration and invasion of colorectal cancer (CRC) cells. METHODS We detected PBX3 expression in five cell lines and surgical specimens from 111 patients with CRC using real-time reverse transcription-polymerase chain reaction. We forced expression of PBX3 in low metastatic HT-29 and SW480 cells and knocked down expression of PBX3 in highly metastatic LOVO and HCT-8 cells. Wound healing and Boyden chamber assays were used to detect cell migration and invasion after altered expression of PBX3. Western blot was performed to detect the change of signaling molecule ERK1/2 following PBX3 overexpression. RESULTS High level of PBX3 expression was correlated with the invasive potential of CRC cells, and significantly associated with lymph node invasion (P = 0.02), distant metastasis (P = 0.04), advanced TNM stage (P = 0.03) and poor overall survival of patients (P < 0.05). Ectopic expression of PBX3 in low metastatic cells was shown to promote migration and invasion, while inhibited PBX3 expression in highly metastatic cells suppressed migration and invasion. Furthermore, upregulation of phosphorylated extracellular signal-regulated kinase (ERK)1/2 was found to be one of the targeted molecules responsible for PBX3-induced CRC cell migration and invasion. CONCLUSION PBX3 induces invasion and metastasis of CRC cells partially through activation of the MAPK/ERK signaling pathway.

[1]  J. Rowley,et al.  PBX3 is an important cofactor of HOXA9 in leukemogenesis. , 2013, Blood.

[2]  Shuji Ogino,et al.  Differential WNT activity in colorectal cancer confers limited tumorigenic potential and is regulated by MAPK signaling. , 2012, Cancer research.

[3]  Kevin J Harrington,et al.  Targeting HOX and PBX transcription factors in ovarian cancer , 2010, BMC Cancer.

[4]  M. Alessio,et al.  PBX1 nuclear export is regulated independently of PBX–MEINOX interaction by PKA phosphorylation of the PBC‐B domain , 2003, The EMBO journal.

[5]  Matthew J. Anderson,et al.  A conserved Pbx-Wnt-p63-Irf6 regulatory module controls face morphogenesis by promoting epithelial apoptosis. , 2011, Developmental cell.

[6]  Jing-Yuan Fang,et al.  TRAPPC4-ERK2 Interaction Activates ERK1/2, Modulates Its Nuclear Localization and Regulates Proliferation and Apoptosis of Colorectal Cancer Cells , 2011, PloS one.

[7]  C. Ratto,et al.  Potential pitfalls concerning colorectal cancer classification in the seventh edition of the AJCC Cancer Staging Manual. , 2011, Diseases of the colon and rectum.

[8]  P. Korkolopoulou,et al.  ERK/pERK expression and B-raf mutations in colon adenocarcinomas: correlation with clinicopathological characteristics , 2012, World Journal of Surgical Oncology.

[9]  Lyn is involved in CD24-induced ERK1/2 activation in colorectal cancer , 2012, Molecular Cancer.

[10]  K. Nakashiro,et al.  PLZF regulates Pbx1 transcription and Pbx1–HoxC8 complex leads to androgen‐independent prostate cancer proliferation , 2006, The Prostate.

[11]  B. Jiang,et al.  PAK1-dependent MAPK pathway activation is required for colorectal cancer cell proliferation , 2012, Tumor Biology.

[12]  J. Gu,et al.  Let‐7c functions as a metastasis suppressor by targeting MMP11 and PBX3 in colorectal cancer , 2012, The Journal of pathology.

[13]  T. Capellini,et al.  Pbx homeodomain proteins: TALEnted regulators of limb patterning and outgrowth , 2011, Developmental dynamics : an official publication of the American Association of Anatomists.

[14]  L. Ricci-Vitiani,et al.  Colon cancer stem cells , 2007, Gut.

[15]  R. Morgan,et al.  Disrupting the interaction between HOX and PBX causes necrotic and apoptotic cell death in the renal cancer lines CaKi-2 and 769-P. , 2008, The Journal of urology.

[16]  R. Morgan,et al.  Targeting the HOX/PBX dimer in breast cancer , 2012, Breast Cancer Research and Treatment.

[17]  L. Ricci-Vitiani,et al.  Colon cancer stem cells , 2009, Journal of Molecular Medicine.

[18]  Y. Hanakawa,et al.  Pre-B-cell leukemia transcription factor 1 is a major target of promyelocytic leukemia zinc-finger-mediated melanoma cell growth suppression , 2007, Oncogene.

[19]  H. Hollema,et al.  MEIS and PBX homeobox proteins in ovarian cancer. , 2007, European journal of cancer.

[20]  P. Mellon,et al.  Activin regulation of the follicle-stimulating hormone beta-subunit gene involves Smads and the TALE homeodomain proteins Pbx1 and Prep1. , 2004, Molecular endocrinology.

[21]  L. Bullinger,et al.  HOXA/PBX3 knockdown impairs growth and sensitizes cytogenetically normal acute myeloid leukemia cells to chemotherapy , 2013, Haematologica.

[22]  S. Deschamps,et al.  PBX proteins: much more than Hox cofactors. , 2008, The International journal of developmental biology.

[23]  R. Morgan,et al.  HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer) , 2009, British Journal of Cancer.

[24]  M. Caligiuri,et al.  Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML. , 2012, Blood.

[25]  Junyan Zhang,et al.  PBX3 is overexpressed in gastric cancer and regulates cell proliferation , 2014, Tumor Biology.

[26]  A. Svindland,et al.  Regulation of PBX3 expression by androgen and Let-7d in prostate cancer , 2011, Molecular Cancer.